HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Germanecki	5/1/2010 3:04:17 PM
	of 1022

S.A. patients helping test novel bone building therapy for multiple myeloma kens5.com .... Now, he’s helping to test a totally new medication. At the U.T. Health Science Center’s Cancer Therapy and Research Center, he gets an intravenous drug. It’s an experimental treatment called BHQ880. It’s an antibody designed to stimulate the bone-forming cells called osteoblasts .... BHQ880 is a human mAB, designed by Morphosys and developped by Novartis. clinicaltrials.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next